期刊文献+

川崎病患儿血清巨噬细胞炎症蛋白-1α含量变化及与冠状动脉扩张的相关性 被引量:6

Relationship between macrophage inflammatory protein-1α and coronary artery dilatation in children with Kawasaki disease
暂未订购
导出
摘要 目的探讨血清巨噬细胞炎症蛋白-1α(MIP-1α)水平在川崎病(KD)患儿中的变化及其与冠状动脉扩张的相关性。方法选取急性期KD患儿30例,其中11例有急性期冠脉扩张;正常对照组20例。采用酶联免疫法检测血清MIP-1α水平,超声心动图检测冠状动脉扩张程度;分析血清MIP-1α水平变化及其与冠脉扩张程度的相关性。结果 KD急性期患儿的血清MIP-1α水平为(82.42±12.16)ng/L,高于正常对照组(37.22±3.41)ng/L,差异有统计学意义(P<0.05);冠脉扩张KD患儿的MIP-1α水平为(88.28±10.10)ng/L,高于冠脉正常KD患儿(73.61±1.26)ng/L,差异有统计学意义(P<0.05)。KD患儿血清MIP-1α水平与冠脉扩张程度呈正相关(r=0.452,P<0.05)。结论 KD急性期患儿的血清MIP-1α水平明显升高,而伴冠脉损伤的KD患儿的水平更高;MIP-1α水平与冠状动脉扩张程度呈正相关。 Objectives To detect serum MIP-1α level in children with Kawasaki disease (KD), and to investigate the re1αtionship between MIP-1α and coronary artery di1αtation. Methods The levels of serum MIP-1α from 30 acute KD patients, among them 11 patients with coronary artery di1αtation, and 20 healthy children were detected by enzyme-linked immuno- sorbent assay. The degree of coronary artery di1αtation was detected by ultrasonic cardiogram and its association with MIP-Ia was performed. Results The level of serum MIP-1α in acute KD patients (82.42±12.16 ng/L) was obviously higher than that in healthy children (37.22±3.41 ng/L) (P〈0.05). The level of serum MIP-1α in acute KD patients with coronary artery di1αta-tion (88.28±10.10ng/L) was higher than that in KD patients with non-coronary artery di1αtation (73.61±1.26 ng/L) (P〈0.05). In addition, the level of serum MIP-1α in KD patients showed positive corre1αtion with the degree of coronary artery di1αta-tion (r=0.452, P〈0.05). Conclusions The level of serum MIP-1α in KD patients is obviously higher and further higher in KD patients with coronary artery di1αtation. The serum MIP-1α level in KD patients shows positive corre1αtion with the degree of coronary artery di1αtation.
机构地区 山西医科大学
出处 《临床儿科杂志》 CAS CSCD 北大核心 2013年第6期519-521,共3页 Journal of Clinical Pediatrics
关键词 川崎病 冠状动脉 巨噬细胞炎症蛋白-1Α Kawasaki disease coronary artery macrophage inflammatory protein-1α
  • 相关文献

参考文献13

  • 1无,赵晓东(整理),杜忠东(整理).川崎病专题讨论会纪要[J].中华儿科杂志,2007,45(11):826-830. 被引量:151
  • 2Hamada H, Terai M, Honda T, et al. Marked pleural and peri- cardial effusion with elevated Vascular Endothelial Growth Factor production:an uncommon complication of Kawasaki disease [J]. Pediatr Int, 2005, 47(1): 112-114.
  • 3Low QE, Drugea IA, Duffner LA, et al. Wound healing in MIP-1α and MCP-1α mice [J]. Am J Pathol, 2001, 159(2): 457-463.
  • 4薛辛东.儿科学[M].2版.北京:人民卫生出版社,2010:141.
  • 5胡亚美,江载芳.诸福棠实用儿科学[M].7版.北京:人民卫生出版社,2002:632-636.
  • 6Du ZD, Zhang T, Liang L, et al. Epidemiologic picture of Kawasaki disesse in Beijing from 1995 through 1999 [J]. Pediatr Infect Dis J, 2002, 21(2): 103-107.
  • 7刘冲,杜忠东.川崎病病因与病理学研究进展[J].国际儿科学杂志,2007,34(4):271-273. 被引量:9
  • 8Terai M, Kohno Y, Namba, M, et aL Class Ⅱ major histocom- patibility antigen expression on coronary arterial endothelium in a patien twith Kawasaki disease [J]. Hum Pathol, 1990, 21(2): 231-234.
  • 9杜忠东.川崎病病因和发病机制研究进展[J].中国实用儿科杂志,2006,21(10):724-726. 被引量:26
  • 10Parissis JT, Adamopoulos S, Venetsanou KF, et al.Serum profiles of C-C chemokines in acute myocardiai infarction: possibie implication in post-infarction left ventricular remodel- ing [J]. J Interfon Cytokine Res, 2002, 22(2): 223-229.

二级参考文献77

  • 1金虹 梁翊常 等.正常儿童冠状动脉超声心动图研究[J].中华儿科杂志,1988,26:257-259.
  • 2Matsubara T,Ichiyama T,Furukawa S.Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasali disease[J].Clin Exper Immunol,2005,141:381-387.
  • 3Terai M,Kohno Y,Namba,M,et al.Class Ⅱ major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease[J].Hum Pathol,1991,21:231.
  • 4Sato N,Sagawa K,Sasaguri Y,et al.Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease[J].J Pediatr,1993,22:198.
  • 5Shulman ST,Rowley AH.Etiology and pathogenesis of Kawasaki disease[J].Prog Pediatr Cardiol,1997,6:187 -192.
  • 6Ichiyama T,Yoshitomi T,Nishikawa M,et al.NF-kappa B activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease[J].Clin Immunol,2001,99:373 -377.
  • 7Ikemoto Y,Teragnchi M,Ono A,et al.Serial changes of plasma nitrate in the acute phase of Kawasaki disease[J].Pediatr Int,2003,45(4):421-425.
  • 8Tsukahara H,Kikuchi K,Matsuda M,et al.Endogenous nitric oxide production in Kawasaki disease[J].Scand J Clin Lab Invest,1997,57(1):43-47.
  • 9Adewuya O,Yasuyuki I,Bian K,et al.Mechanism of vasculitis and aneurysms in Kawasaki disease:role of nitride oxide[J].Nitric Oxide,2003,8:15-25.
  • 10Gavin PJ,Crawford SE,Shulman ST,et al.Systemic arterial expression of matrix metalloproteinases 2 and 9 in acute Kawasaki disease[J].Vasc Bio1,2003,23:576-581.

共引文献2151

同被引文献51

  • 1徐卫军,高宙,李泉水,李成荣,赵春玉.川崎病冠状动脉管壁非扩张性病变及其功能改变的研究[J].中华儿科杂志,2004,42(8):613-616. 被引量:18
  • 2夏颖,王瑞红,朱欢欢.应用临床路径开展冠心病患者的健康教育[J].现代护理,2006,12(25):2431-2432. 被引量:31
  • 3葛伟,孙若鹏.川崎病病因及发病机制研究进展[J].实用儿科临床杂志,2006,21(21):1511-1513. 被引量:8
  • 4薛辛东.儿科学[M].2版.北京:人民卫生出版社,2010:141.
  • 5诸福棠,胡亚美,江载芳.实用儿科学[M].第7版,北京:人民卫生出版社,2002.2559-2565.
  • 6Schw edhelmE,TsikasD,DurandT, et al. Tandem mass spectro- metric uantification of 8-iso-pristagland in F2n and itsmetabo lite 2,3-dinor-5-dihydro, 8-isoprostaglan in F2a in human urine[J]. JChromatograph B, 2000,744 (1) : 99-112.
  • 7Kuo HC,Yang KD,Chang WC. Kawasaki disease:an update on diagnosis and treatment[J].Pediatr Neonatol,2012,(01):4-11.
  • 8Ogata S, Ogibara Y, Honda T,et al.Conicosteroid pulse com-bina ti on therapy for refraetory Kawasakl discase : a ran- domized trial[J].Pediatrics, 2012,129 ( 1 ) : e17-e23.
  • 9袁剑云,英立平.临床护理路径实施手册[M].北京:北京医科大学出版社,2002:278-279.
  • 10Dominggucz SR,Andcrson MS.Advanccs in the treatment of Kawasaki discase[J].Curr Opin Pediatr, 2013,25 (1) : 103-109.

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部